TY - JOUR
T1 - Carbohydrate clearance receptors in transfusion medicine
AU - Sørensen, Anne Louise Tølbøll
AU - Clausen, Henrik
AU - Wandall, Hans H
N1 - Copyright © 2012 Elsevier B.V. All rights reserved.
PY - 2012/11
Y1 - 2012/11
N2 - BACKGROUND: Complex carbohydrates play important functions for circulation of proteins and cells. They provide protective shields and refraction from non-specific interactions with negative charges from sialic acids to enhance circulatory half-life. For recombinant protein therapeutics carbohydrates are especially important to enhance size and reduce glomerular filtration loss. Carbohydrates are, however, also ligands for a large number of carbohydrate-binding lectins exposed to the circulatory system that serve as scavenger receptors for the innate immune system, or have more specific roles in targeting of glycoproteins and cells.SCOPE OF REVIEW: Here we provide an overview of the common lectin receptors that play roles for circulating glycoproteins and cells, and present a discussion of ways to engineer glycosylation of recombinant biologics and cells to improve therapeutic effects.MAJOR CONCLUSIONS: While the pharmaceutical industry has learned how to exploit carbohydrates to improve pharmacokinetic properties of recombinant therapeutics, our understanding of how to improve cell-based therapies by manipulation of complex carbohydrates is still at its infancy. Progress with the latter has recently been achieved with cold-stored platelets, where exposure of uncapped glycans lead to rapid clearance from circulation by several lectin-mediated pathways.GENERAL SIGNIFICANCE: Understanding lectin-mediated clearance pathways is essential for progress in development of biological pharmaceuticals.
AB - BACKGROUND: Complex carbohydrates play important functions for circulation of proteins and cells. They provide protective shields and refraction from non-specific interactions with negative charges from sialic acids to enhance circulatory half-life. For recombinant protein therapeutics carbohydrates are especially important to enhance size and reduce glomerular filtration loss. Carbohydrates are, however, also ligands for a large number of carbohydrate-binding lectins exposed to the circulatory system that serve as scavenger receptors for the innate immune system, or have more specific roles in targeting of glycoproteins and cells.SCOPE OF REVIEW: Here we provide an overview of the common lectin receptors that play roles for circulating glycoproteins and cells, and present a discussion of ways to engineer glycosylation of recombinant biologics and cells to improve therapeutic effects.MAJOR CONCLUSIONS: While the pharmaceutical industry has learned how to exploit carbohydrates to improve pharmacokinetic properties of recombinant therapeutics, our understanding of how to improve cell-based therapies by manipulation of complex carbohydrates is still at its infancy. Progress with the latter has recently been achieved with cold-stored platelets, where exposure of uncapped glycans lead to rapid clearance from circulation by several lectin-mediated pathways.GENERAL SIGNIFICANCE: Understanding lectin-mediated clearance pathways is essential for progress in development of biological pharmaceuticals.
KW - Animals
KW - Carbohydrate Metabolism
KW - Endocytosis
KW - Glycosylation
KW - Humans
KW - Hyaluronan Receptors/physiology
KW - Lectins, C-Type/physiology
KW - Macrophage-1 Antigen/physiology
KW - Mannose Receptor
KW - Mannose-Binding Lectins/physiology
KW - Metabolic Clearance Rate
KW - Platelet Transfusion
KW - Receptors, Cell Surface/physiology
KW - Receptors, Mitogen/physiology
KW - Recombinant Proteins/therapeutic use
U2 - 10.1016/j.bbagen.2012.07.008
DO - 10.1016/j.bbagen.2012.07.008
M3 - Review
C2 - 22846227
SN - 0006-3002
VL - 1820
SP - 1797
EP - 1808
JO - Biochimica et Biophysica Acta
JF - Biochimica et Biophysica Acta
IS - 11
ER -